<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01895309</url>
  </required_header>
  <id_info>
    <org_study_id>SB4-G31-RA</org_study_id>
    <nct_id>NCT01895309</nct_id>
  </id_info>
  <brief_title>A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy</brief_title>
  <official_title>A Randomised, Double-blind, Parallel Group, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity of SB4 Compared to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Bioepis Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Bioepis Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, parallel group, multicentre clinical study to evaluate
      the efficacy, safety, pharmacokinetics and immunogenicity of SB4 compared to Enbrel in
      subjects with moderate to severe Rheumatoid Arthritis (RA) despite Methotrexate (MTX)
      therapy. In some countries, after 52 weeks of treatment with either SB4 or Enbrel, subjects
      will be enrolled into an open label extension period. Subjects will receive SB4 for an
      additional 48 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>American College of Rheumatology 20% Response Criteria (ACR20)</measure>
    <time_frame>Week 24</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ACR20</measure>
    <time_frame>Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>American College of Rheumatology 50% Response Criteria (ACR50)</measure>
    <time_frame>Week 24, Week 52</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">596</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>SB4 (proposed biosimilar to etanercept)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SB4 50 mg/week via subcutaneous injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enbrel (etanercept)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Enbrel 50 mg/week via subcutaneous injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enbrel (etanercept)</intervention_name>
    <arm_group_label>Enbrel (etanercept)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SB4 (proposed biosimilar to etanercept)</intervention_name>
    <arm_group_label>SB4 (proposed biosimilar to etanercept)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed as having RA according to the revised 1987 ACR criteria for at least 6
             months but not exceeding 15 years prior to Screening

          -  Have moderate to severe active disease despite MTX therapy defined as having more than
             or equal to six swollen joints and more than or equal to six tender joints and either
             erythrocyte sedimentation rate (ESR, Westergren) ≥ 28 mm/h or serum C-reactive protein
             ≥ 1.0 mg/dL

          -  Must have been treated with MTX for at least 6 months prior to Randomisation and on a
             stable dose of MTX 10-25 mg/week given at least 4 weeks prior to Screening

          -  Female subjects who are not pregnant or nursing at Screening and who are not planning
             to become pregnant from Screening until 2 months after the last dose of
             investigational product

        Exclusion Criteria:

          -  Have been treated previously with any biological agents including any tumour necrosis
             factor inhibitor

          -  Have a known hypersensitivity to human immunoglobulin proteins or other components of
             Enbrel or SB4

          -  Have a positive serological test for hepatitis B or hepatitis C or have a known
             history of infection with human immunodeficiency virus

          -  Have a current diagnosis of active tuberculosis

          -  Have had a serious infection or have been treated with intravenous antibiotics for an
             infection within 8 weeks or oral antibiotics within 2 weeks prior to Randomisation.

          -  Have any of the following conditions

               1. Other inflammatory or rheumatic diseases.

               2. History of any malignancy within the previous 5 years prior to Screening

               3. History of lymphoproliferative disease including lymphoma.

               4. History of congestive heart failure

               5. Physical incapacitation (ACR functional Class IV or wheelchair-/bed-bound).

               6. History of demyelinating disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jiri Vencovsky, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charles University, Czech Republic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Investigational Site</name>
      <address>
        <city>Kielce</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site</name>
      <address>
        <city>Southampton</city>
        <state>Hampshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2013</study_first_submitted>
  <study_first_submitted_qc>July 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2013</study_first_posted>
  <results_first_submitted>July 13, 2016</results_first_submitted>
  <results_first_submitted_qc>July 13, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 29, 2016</results_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>Etanercept</keyword>
  <keyword>Biosimilar</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methotrexate</mesh_term>
    <mesh_term>Etanercept</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SB4 (Proposed Biosimilar to Etanercept)</title>
          <description>SB4 50 mg/week via subcutaneous injection</description>
        </group>
        <group group_id="P2">
          <title>Enbrel (Etanercept)</title>
          <description>Enbrel 50 mg/week via subcutaneous injection</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="299"/>
                <participants group_id="P2" count="297"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="259"/>
                <participants group_id="P2" count="246"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SB4 (Proposed Biosimilar to Etanercept)</title>
          <description>SB4 50 mg/week via subcutaneous injection</description>
        </group>
        <group group_id="B2">
          <title>Enbrel (Etanercept)</title>
          <description>Enbrel 50 mg/week via subcutaneous injection</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="299"/>
            <count group_id="B2" value="297"/>
            <count group_id="B3" value="596"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.1" spread="11.72"/>
                    <measurement group_id="B2" value="51.6" spread="11.63"/>
                    <measurement group_id="B3" value="51.8" spread="11.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="249"/>
                    <measurement group_id="B2" value="253"/>
                    <measurement group_id="B3" value="502"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>American College of Rheumatology 20% Response Criteria (ACR20)</title>
        <time_frame>Week 24</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SB4 (Proposed Biosimilar to Etanercept)</title>
            <description>SB4 50 mg/week via subcutaneous injection</description>
          </group>
          <group group_id="O2">
            <title>Enbrel (Etanercept)</title>
            <description>Enbrel 50 mg/week via subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>American College of Rheumatology 20% Response Criteria (ACR20)</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="247"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.1"/>
                    <measurement group_id="O2" value="80.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ACR20</title>
        <time_frame>Week 52</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SB4 (Proposed Biosimilar to Etanercept)</title>
            <description>SB4 50 mg/week via subcutaneous injection</description>
          </group>
          <group group_id="O2">
            <title>Enbrel (Etanercept)</title>
            <description>Enbrel 50 mg/week via subcutaneous injection</description>
          </group>
        </group_list>
        <measure>
          <title>ACR20</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="224"/>
                <count group_id="O2" value="216"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.8"/>
                    <measurement group_id="O2" value="81.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>American College of Rheumatology 50% Response Criteria (ACR50)</title>
        <time_frame>Week 24, Week 52</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SB4 (Proposed Biosimilar to Etanercept) at Week 24</title>
            <description>SB4 50 mg/week via subcutaneous injection
SB4 (proposed biosimilar to etanercept)</description>
          </group>
          <group group_id="O2">
            <title>Enbrel (Etanercept) at Week 24</title>
            <description>Enbrel 50 mg/week via subcutaneous injection
Enbrel (etanercept)</description>
          </group>
          <group group_id="O3">
            <title>SB4 (Proposed Biosimilar to Etanercept) at Week 52</title>
            <description>SB4 50 mg/week via subcutaneous injection
SB4 (proposed biosimilar to etanercept)</description>
          </group>
          <group group_id="O4">
            <title>Enbrel (Etanercept) at Week 52</title>
            <description>Enbrel 50 mg/week via subcutaneous injection
Enbrel (etanercept)</description>
          </group>
        </group_list>
        <measure>
          <title>American College of Rheumatology 50% Response Criteria (ACR50)</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="247"/>
                <count group_id="O2" value="236"/>
                <count group_id="O3" value="224"/>
                <count group_id="O4" value="216"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.2"/>
                    <measurement group_id="O2" value="42.4"/>
                    <measurement group_id="O3" value="58.5"/>
                    <measurement group_id="O4" value="53.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>SB4 (Proposed Biosimilar to Etanercept)</title>
          <description>SB4 50 mg/week via subcutaneous injection
SB4 (proposed biosimilar to etanercept)</description>
        </group>
        <group group_id="E2">
          <title>Enbrel (Etanercept)</title>
          <description>Enbrel 50 mg/week via subcutaneous injection
Enbrel (etanercept)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 16.0</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="299"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Chorioretinopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Device Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile Duct Stone</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gallbladder Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Liver Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rheumatoid Arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Still'S Disease Adult Onset</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma Gastric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Invasive Ductal Breast Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Ovarian Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Uterine Polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Vaginal Prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 16.0</default_vocab>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="175" subjects_at_risk="299"/>
                <counts group_id="E2" subjects_affected="179" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Anaemia Of Chronic Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cardiovascular Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Mitral Valve Prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Ear Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>External Ear Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Thyroid Cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eyelid Oedema</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Conjunctival Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dry Eye</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Eye Irritation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Eyelid Ptosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Vision Blurred</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Chorioretinopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Presbyopia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="299"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Diverticulum Intestinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Enterocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Irritable Bowel Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Parotid Gland Inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dry Mouth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Portal Hypertensive Gastropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Reflux Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection Site Erythema</sub_title>
                <counts group_id="E1" events="16" subjects_affected="6" subjects_at_risk="299"/>
                <counts group_id="E2" events="85" subjects_affected="33" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Influenza Like Illness</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Rash</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="11" subjects_affected="6" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Device Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Hypersensitivity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="10" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="13" subjects_affected="8" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Application Site Erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="18" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Application Site Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Face Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Feeling Hot</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Bruising</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Site Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Soft Tissue Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Liver Disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cholecystitis Chronic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Bile Duct Stone</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Biliary Colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gallbladder Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypertransaminasaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy To Arthropod Bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="28" subjects_affected="24" subjects_at_risk="299"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="299"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="299"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="299"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="299"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="299"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="299"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Oral Herpes</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Asymptomatic Bacteriuria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Otitis Externa</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pharyngotonsillitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Viral Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Acute Tonsillitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Bacteriuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Chronic Tonsillitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Fungal Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Herpes Simplex</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Liver Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Localised Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lyme Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Otitis Media</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pharyngitis Bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rash Pustular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tinea Pedis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tinea Versicolour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tooth Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Acute Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Eczema Infected</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Herpes Virus Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lobar Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Nail Candida</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Peritonitis Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pulpitis Dental</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Viral Rhinitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Head Injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Arthropod Bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hand Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Joint Dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Ligament Sprain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Muscle Strain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Traumatic Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Fibula Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injection Related Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Limb Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lumbar Vertebral Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Thermal Burn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="25" subjects_affected="18" subjects_at_risk="299"/>
                <counts group_id="E2" events="26" subjects_affected="17" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="13" subjects_affected="8" subjects_at_risk="299"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Gamma-Glutamyltransferase Increased</sub_title>
                <counts group_id="E1" events="11" subjects_affected="5" subjects_at_risk="299"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lymphocyte Count Decreased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Transaminases Increased</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Blood Pressure Increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Liver Function Test Abnormal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Blood Alkaline Phosphatase Increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Blood Glucose Increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Increased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Neutrophil Count Decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Blood Urine Present</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Haemoglobin Decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Neutrophil Count Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Nitrite Urine Present</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Urine Analysis Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Weight Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Blood Calcium Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Blood Phosphorus Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lymphocyte Count Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lymphocyte Count Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Platelet Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Platelet Count Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dyslipidaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Metabolic Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rheumatoid Arthritis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="299"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="10" subjects_affected="5" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pain In Extremity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Fracture Delayed Union</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Groin Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Sjogren'S Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Still'S Disease Adult Onset</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Bone Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Enthesopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Joint Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Nuchal Rigidity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Osteoporotic Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Periostitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Spinal Deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Uterine Leiomyoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Gastric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Basal Cell Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Haemangioma Of Liver</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Melanocytic Naevus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Breast Fibroma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Invasive Ductal Breast Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pyogenic Granuloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="299"/>
                <counts group_id="E2" events="16" subjects_affected="8" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Anosmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Disturbance In Attention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dystonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Parosmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Stupor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Balance Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypertensive Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Loss Of Consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Lumbar Radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Sleep Disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Anxiety Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Initial Insomnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tachyphrenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Neurosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Calculus Bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Renal Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Urinary Tract Inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Amenorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Breast Mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Breast Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Breast Swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Cervical Polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Ovarian Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Uterine Polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Vaginal Prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Breast Induration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Menopausal Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Inflammation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Nasal Congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Productive Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rhinitis Allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Tonsillar Hypertrophy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Nasal Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rhinitis Atrophic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dry Skin</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rash Papular</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dermatitis Allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Erythema Annulare</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Onychoclasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rash Pruritic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Rosacea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Skin Mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Dermatitis Contact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Prurigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Umbilical Erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Menopause</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Tooth Extraction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="16" subjects_affected="11" subjects_at_risk="299"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="299"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="297"/>
              </event>
              <event>
                <sub_title>Pallor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="299"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="297"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>At least sixty (60) days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy of all such manuscripts and materials, and allow Sponsor sixty (60) days to review and comment on them. If the Sponsor requests, the Site shall remove any Confidential Information (other than Study results) prior to submitting or presenting the materials.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director, Clinical Development</name_or_title>
      <organization>Samsung Bioepis</organization>
      <phone>+82 31 8061 4534</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

